125 related articles for article (PubMed ID: 35165900)
1. An engineered abcb4 expression model reveals the central role of NF-κB in the regulation of drug resistance in zebrafish.
Sun CJ; Hu RY; Li ZC; Jin L; Lu H; He ZX; Shu LP
Drug Dev Res; 2022 Jun; 83(4):927-939. PubMed ID: 35165900
[TBL] [Abstract][Full Text] [Related]
2. [Wnt/β-catenin signaling pathway involved in the expression and drug resistance of abcb4 gene in transgenic zebrafish induced by chemotherapeutic drugs].
Chen L; Xiang W; Mo J; Sun C; Zhou Y; Wu X; He Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Feb; 35(2):134-139. PubMed ID: 30975277
[TBL] [Abstract][Full Text] [Related]
3. [Effect of Doxorubicin on abcb4 Gene Expression in Zebrafish (Danio rerio) Embryos].
Sun CJ; He ZX; Shu LP; Hu RY; He SJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 47(1):7-13. PubMed ID: 27062773
[TBL] [Abstract][Full Text] [Related]
4. Regulation of hepatic abcb4 and cyp3a65 gene expression and multidrug/multixenobiotic resistance (MDR/MXR) functional activity in the model teleost, Danio rerio (zebrafish).
Jackson JS; Kennedy CJ
Comp Biochem Physiol C Toxicol Pharmacol; 2017 Oct; 200():34-41. PubMed ID: 28624525
[TBL] [Abstract][Full Text] [Related]
5. Abcb4 acts as multixenobiotic transporter and active barrier against chemical uptake in zebrafish (Danio rerio) embryos.
Fischer S; Klüver N; Burkhardt-Medicke K; Pietsch M; Schmidt AM; Wellner P; Schirmer K; Luckenbach T
BMC Biol; 2013 Jun; 11():69. PubMed ID: 23773777
[TBL] [Abstract][Full Text] [Related]
6. Effects of pharmaceuticals and personal care products (PPCPs) on multixenobiotic resistance (MXR) related efflux transporter activity in zebrafish (Danio rerio) embryos.
Cunha V; Burkhardt-Medicke K; Wellner P; Santos MM; Moradas-Ferreira P; Luckenbach T; Ferreira M
Ecotoxicol Environ Saf; 2017 Feb; 136():14-23. PubMed ID: 27810576
[TBL] [Abstract][Full Text] [Related]
7. Characterization and tissue localization of zebrafish homologs of the human ABCB1 multidrug transporter.
Robey RW; Robinson AN; Ali-Rahmani F; Huff LM; Lusvarghi S; Vahedi S; Hotz JM; Warner AC; Butcher D; Matta J; Edmondson EF; Lee TD; Roth JS; Lee OW; Shen M; Tanner K; Hall MD; Ambudkar SV; Gottesman MM
Sci Rep; 2021 Dec; 11(1):24150. PubMed ID: 34921178
[TBL] [Abstract][Full Text] [Related]
8. Chemical effects on dye efflux activity in live zebrafish embryos and on zebrafish Abcb4 ATPase activity.
Bieczynski F; Burkhardt-Medicke K; Luquet CM; Scholz S; Luckenbach T
FEBS Lett; 2021 Mar; 595(6):828-843. PubMed ID: 33274443
[TBL] [Abstract][Full Text] [Related]
9. Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway.
Jiang L; Wang P; Sun YJ; Wu YJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):265. PubMed ID: 31215501
[TBL] [Abstract][Full Text] [Related]
10. Zebrafish Abcb4 is a potential efflux transporter of microcystin-LR.
Lu X; Long Y; Sun R; Zhou B; Lin L; Zhong S; Cui Z
Comp Biochem Physiol C Toxicol Pharmacol; 2015 Jan; 167():35-42. PubMed ID: 25193616
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of a zebrafish knockout model of abcb4, a homolog of the human multidrug efflux transporter P-glycoprotein.
Park J; Kim H; Alabdalla L; Mishra S; Mchaourab H
Hum Genomics; 2023 Sep; 17(1):84. PubMed ID: 37674192
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB plays a central role in vincristine resistance in multiple myeloma cells.
Tsubaki M; Takeda T; Ogawa N; Sakamoto K; Shimaoka H; Fujita A; Itoh T; Imano M; Ishizaka T; Satou T; Nishida S
Leuk Res; 2015 Apr; 39(4):445-52. PubMed ID: 25726084
[TBL] [Abstract][Full Text] [Related]
13. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
[TBL] [Abstract][Full Text] [Related]
14. Dacomitinib potentiates the efficacy of conventional chemotherapeutic agents via inhibiting the drug efflux function of ABCG2 in vitro and in vivo.
Guo X; To KKW; Chen Z; Wang X; Zhang J; Luo M; Wang F; Yan S; Fu L
J Exp Clin Cancer Res; 2018 Feb; 37(1):31. PubMed ID: 29458405
[TBL] [Abstract][Full Text] [Related]
15. Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1.
Sims JT; Ganguly SS; Bennett H; Friend JW; Tepe J; Plattner R
PLoS One; 2013; 8(1):e55509. PubMed ID: 23383209
[TBL] [Abstract][Full Text] [Related]
16. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
[TBL] [Abstract][Full Text] [Related]
17. A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo.
Liu RM; Xu P; Chen Q; Feng SL; Xie Y
Phytomedicine; 2020 Dec; 79():153342. PubMed ID: 32992085
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of a zebrafish knockout model of abcb4, a homolog of the human multidrug efflux transporter P-glycoprotein.
Park J; Kim H; Alabdalla L; Mishra S; Mchaourab H
Res Sq; 2023 Jul; ():. PubMed ID: 37546821
[TBL] [Abstract][Full Text] [Related]
19. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of ABCB4 contributes to acquired doxorubicin resistance in breast cancer cells in vitro.
Huang JF; Wen CJ; Zhao GZ; Dai Y; Li Y; Wu LX; Zhou HH
Cancer Chemother Pharmacol; 2018 Aug; 82(2):199-210. PubMed ID: 29777275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
